Particle radiotherapy in the era of radioimmunotherapy
- PMID: 37331583
- DOI: 10.1016/j.canlet.2023.216268
Particle radiotherapy in the era of radioimmunotherapy
Abstract
Radiotherapy (RT) is one of the key modalities for cancer treatment, and more than 70% of tumor patients will receive RT during the course of their disease. Particle radiotherapy, such as proton radiotherapy, carbon-ion radiotherapy (CIRT) and boron neutron capture therapy (BNCT), is currently available for the treatment of patients Immunotherapy combined with photon RT has been successfully used in the clinic. The effect of immunotherapy combined with particle RT is an area of interest. However, the molecular mechanisms underlying the effects of combined immunotherapy and particle RT remain largely unknown. In this review, we summarize the properties of different types of particle RT and the mechanisms underlying their radiobiological effects. Additionally, we compared the main molecular players in photon RT and particle RT and the mechanisms involved the RT-mediated immune response.
Keywords: Boron neutron capture therapy; Carbon-ion radiotherapy; Immunotherapy; Proton radiotherapy; Radiobiology.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no competing interests.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
